M
Matthias M. Dollinger
Researcher at Martin Luther University of Halle-Wittenberg
Publications - 96
Citations - 4312
Matthias M. Dollinger is an academic researcher from Martin Luther University of Halle-Wittenberg. The author has contributed to research in topics: Liver transplantation & Sorafenib. The author has an hindex of 31, co-authored 93 publications receiving 3914 citations. Previous affiliations of Matthias M. Dollinger include University of Ulm & Luther University.
Papers
More filters
Journal ArticleDOI
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial
Rafael Bañares,Rafael Bañares,Frederik Nevens,Fin Stolze Larsen,Rajiv Jalan,Agustín Albillos,Matthias M. Dollinger,Faouzi Saliba,Faouzi Saliba,Tilman Sauerbruch,Sebastian Klammt,Johann Ockenga,Albert Parés,Julia Wendon,Tanja Brünnler,Ludwig Kramer,Philippe Mathurin,Manuel de la Mata,Antonio Gasbarrini,Beat Müllhaupt,Alexander Wilmer,Wim Laleman,Martin Eefsen,Sambit Sen,Alexander Zipprich,Teresa Tenorio,Marco Pavesi,Hartmut Schmidt,Steffen Mitzner,Roger Williams,Vicente Arroyo +30 more
TL;DR: At scheduled doses, a beneficial effect on survival of MARS therapy in patients with ACLF could not be demonstrated, however, MARS has an acceptable safety profile, has significant dialysis effect, and nonsignificantly improves severe HE.
Journal ArticleDOI
Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo
H. Aurich,M Sgodda,P Kaltwasser,M Vetter,Anja Weise,Thomas Liehr,Marc Brulport,Jan G. Hengstler,Matthias M. Dollinger,Wolfgang E. Fleig,Bruno Christ +10 more
TL;DR: Pre-differentiation of human MSCs from adipose tissue into hepatocyte-like cells in vitro facilitates long term functional hepatic integration in vivo.
Journal ArticleDOI
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
David Malka,Pascale Cervera,Stéphanie Foulon,Tanja Trarbach,Christelle De La Fouchardiere,Eveline Boucher,Laetitia Fartoux,Sandrine Faivre,Jean-Frédéric Blanc,Frédéric Viret,Eric Assenat,Thomas Seufferlein,Thomas Herrmann,Julien Grenier,Pascal Hammel,Matthias M. Dollinger,Thierry André,Philipp Hahn,Volker Heinemann,Vanessa Rousseau,Michel Ducreux,Jean-Pierre Pignon,Dominique Wendum,Olivier Rosmorduc,Tim F. Greten +24 more
TL;DR: The addition of cetuximab to gemcitabine and oxaliplatin did not seem to enhance the activity of chemotherapy in patients with advanced biliary cancer, although it was well tolerated.
Journal ArticleDOI
Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers
Ines Aurich,Lutz P. Mueller,H. Aurich,Jana Luetzkendorf,Kai Tisljar,Matthias M. Dollinger,Wiebke Schormann,Jens Walldorf,Jan G. Hengstler,Wolfgang E. Fleig,Bruno Christ +10 more
TL;DR: It is demonstrated that human MSCs gain in vitro the characteristic morphology and function of hepatocytes in response to specified growth factors, indicating that the transplanted cells retain prominent qualities of hepatocyte after their regional integration.
Journal ArticleDOI
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis
Alexander Zipprich,Guadalupe Garcia-Tsao,Sebastian Rogowski,Wolfgang E. Fleig,Thomas Seufferlein,Matthias M. Dollinger +5 more
TL;DR: The objectives of this study were to analyse survival of the different stages and substages of cirrhosis and to examine the prognostic value of the hepatic venous pressure gradient (HVPG) at each of the stages.